Management of Primary Plasma Cell Leukemia Remains Challenging Even in the Era of Novel Agents

por Chaulagain, Chakra P, Diacovo, Maria-Julia, Van, Amy, Martinez, Felipe, Fu, Chieh-Lin, Jimenez Jimenez, Antonio Martin, Ahmed, Wesam, Anwer, Faiz
Publicado 2021

Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia

por Gui, Gege, Dillon, Laura W., Ravindra, Niveditha, Hegde, Pranay S., Andrew, Georgia, Mukherjee, Devdeep, Wong, Zoë, Auletta, Jeffery, El Chaer, Firas, Chen, Evan, Chen, Yi-Bin, Corner, Adam, Devine, Steven M., Iyer, Sunil, Jimenez Jimenez, Antonio Martin, De Lima, Marcos J.G., Litzow, Mark R., Kebriaei, Partow, Spellman, Stephen R, Zeger, Scott L., Page, Kristin M., Hourigan, Christopher S.
Publicado 2023